Legal & General Group PLC Fulcrum Therapeutics, Inc. Transaction History
Legal & General Group PLC
- $368 Billion
- Q4 2024
A detailed history of Legal & General Group PLC transactions in Fulcrum Therapeutics, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 6,520 shares of FULC stock, worth $19,038. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,520
Previous 6,520
-0.0%
Holding current value
$19,038
Previous $23,000
30.43%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding FULC
# of Institutions
131Shares Held
51.4MCall Options Held
1.04MPut Options Held
32.6K-
Ra Capital Management, L.P. Boston, MA10.2MShares$29.9 Million0.78% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA5.25MShares$15.3 Million4.03% of portfolio
-
Black Rock Inc. New York, NY4.8MShares$14 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT4.78MShares$14 Million1.13% of portfolio
-
Suvretta Capital Management, LLC New York, NY3.34MShares$9.75 Million0.65% of portfolio
About Fulcrum Therapeutics, Inc.
- Ticker FULC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,038,900
- Market Cap $152M
- Description
- Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...